ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HTFL vs JNJ // EV/EBITDA & P/E VALUATION

Heartflow Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: HTFL 5 — JNJ 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HTFL VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HTFL JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 76.80% 67.90% +8.90 HTFL /gross-margins <GO>
Return on Invested Capital (ROIC) -12.00% 25.50% -37.50 JNJ /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 18.5x — TIE /valuation <GO>
Free Cash Flow Yield -1.12% 2.97% -4.09 JNJ /fcf-yield <GO>
Operating Margin -36.40% 34.70% -71.10 JNJ /operating-margins <GO>
Net Profit Margin -60.00% 28.50% -88.50 JNJ /net-margins <GO>
Revenue Growth (YoY) 39.90% 6.00% +33.90 HTFL /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 26.00 5.59 +20.41 HTFL /balance-sheet <GO>
Piotroski F-Score Quality 5/9 8/9 -3.00 JNJ /piotroski-score <GO>
Options Implied Move & Put/Call Skew 6.60% 7.20% -0.60 HTFL /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 67.3 60.4 +6.96 HTFL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.90 1.08 -0.18 JNJ /macro-sensitivity <GO>
Forward P/E Multiple 27.0x 23.0x +4.00 JNJ /forward-pe <GO>
Enterprise Scale & Market Cap $5.26B $662.49B -$657.23B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HTFL REV JNJ REV HTFL GROSS % JNJ GROSS % HTFL FCF JNJ FCF
FY 2025 $176.0M $94.19B 76.8% 67.9% -$59.0M $19.70B
FY 2024 $125.8M $88.82B 75.1% 69.1% -$73.4M $19.84B
FY 2023 $87.2M $85.16B 44.0% 44.0% -$80.4M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HTFL // BETA 0.90
JNJ // BETA 1.08